Abiopharma

FIDELITY D & D BANCORP INC (FDBC) Reports the reporting period Financial Results FIDELITY D & D BANCORP INC (FDBC) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: 1.36
• Net Income: 7460
• EPS: 1.28
• Cash and equivalents: 175362
  • anticipated in these forward-looking statements due to a variety of factors, including, without limitation: ■ local, regional and national economic conditions and changes thereto; ■ the short-term and long-term effects of inflation, and rising costs to the Company, its customers and on the economy; ■ the risks of changes and volatility of interest rates on the level and composition of deposits, loan demand, and the values of loan collateral, securities and interest rate protection agreements, as well as interest rate risks; ■ securities markets and monetary fluctuations and volatility; ■ disruption of credit and equity markets; ■ impacts of the capital and liquidity requirements of the Basel III standards and other regulatory pronouncements, regulations and rules; ■ governmental monetary and fiscal policies, as well as legislative and regulatory changes; ■ effects of short- and long-term federal budget and tax negotiations and their effect on economic and business conditions; ■ the costs and effects of litigation and of unexpected or adverse outcomes in such litigation; ■ the impact of new or changes in existing laws and regulations, including laws and regulations concerning taxes, banking, securities and insurance and their application with which the Company and its subsidiaries must comply; ■ the effect of changes in accounting policies and practices, as may be adopted by the regulatory agencies, as well as the Financial Accounting Standards Board and other accounting standard setters; ■ the effects of competition from other commercial banks, thrifts, mortgage banking firms, consumer finance companies, credit unions, securities brokerage firms, insurance companies, money market and other mutual funds and other financial institutions operating in our market area and elsewhere, including institutions operating locally, regionally, nationally and internationally, together with such competitors offering banking products and services by mail, telephone, computer and the internet; ■ the effects of economic conditions of any other pandemic, epidemic or other health-related crisis such as COVID-19 and responses thereto on current customers and the operations of the Company, specifically the effect of the economy on loan customers’ ability to repay loans; ■ the effects of bank failures, banking system instability, deposit fluctuations, loan and securities value changes; ■ technological changes; ■ the interruption or breach in security of our information systems, continually evolving cybersecurity and other technological risks and attacks resulting in failures or disruptions in customer account management, general ledger processing and loan or deposit updates and potential impacts resulting therefrom including additional costs, reputational damage, regulatory penalties, and financial losses; ■ acquisitions and integration of acquired businesses; ■ the failure of assumptions underlying the establishment of reserves for loan losses and estimations of values of collateral and various financial assets and liabilities; ■ acts of war, terrorism, or armed conflict; and ■ the risk that our analyses of these risks and forces could be incorrect and/or that the strategies developed to address them could be unsuccessful. The Company cautions readers not to place undue reliance on forward-looking statements, which reflect analyses only as of the date of this release. The Company has no obligation to update any forward-looking statements to reflect events or circumstances after the date of this release. For more information please visit our investor relations web site located through www.bankatfidelity.com. FIDELITY D & D BANCORP, INC. Unaudited Condensed Consolidated Balance Sheets (dollars in thousands)  At Period End: March 31, 2026